DV
Dividend Vision

FENC — Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc (FENC)

Total return is -89.7% over the past 21.8 years, 965.7 points behind SPY at 876.0%. Its deepest 1-year drawdown was 41.6%.

This is a single-stock equity holding in Fennec Pharmaceuticals Inc, a pharmaceutical company, rather than a diversified ETF. With no distribution rate listed, it does not currently function as an income-generating investment. The lack of available expense ratio and AUM data, combined with the single-stock structure, suggests this may not be a traditional dividend-focused ETF but rather a direct equity position, making it suitable primarily for investors seeking capital appreciation or exposure to the pharmaceutical sector rather than dividend income.

FENC key facts

Asset type
Stock
Asset class
Equity
Inception date
11/12/2004
Last close
$11.72
Market cap
$364,738,848
Average volume
106941.0
Beta
1.069
Payout ratio
0.0
Forward P/E
41.1523
EPS
$-0.29